Showing results (411-420 of 496) with videos related to
Sort By:
Pageof 50
Cell Reports|October 24, 2024
Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapySunita Keshari, Alexander S Shavkunov, Qi Miao, et al.Immunity|May 31, 2024
An inducible genetic tool to track and manipulate specific microglial states reveals their plasticity and roles in remyelinationKia M Barclay, Nora Abduljawad, Zuolin Cheng, et al.Clinical and Translational Medicine|August 28, 2022
IL-34 deficiency impairs FOXP3+ Treg function in a model of autoimmune colitis and decreases immune tolerance homeostasisAntoine Freuchet, Apolline Salama, Séverine Bézie, et al.Science (New York, N.Y.)|March 5, 2026
Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapyYun Chen, Yizhou Liu, Khai Nguyen, et al.Proceedings of the National Academy of Sciences of the United States of America|January 15, 2021
Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer's diseaseDaniel C Ellwanger, Shoutang Wang, Simone Brioschi, et al.Nature Communications|June 11, 2026
Bone-derived Osterix+ osteolineage cells are a source of tumor-promoting myofibroblastic cancer-associated fibroblasts in breast cancerGiulia Furesi, Carisa Zeng, Emily M Eul, et al.Scientific Reports|April 28, 2015
Developing the IVIG biomimetic, hexa-Fc, for drug and vaccine applicationsDaniel M Czajkowsky, Jan Terje Andersen, Anja Fuchs, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 14, 2019
IL-22 is required for the induction of bronchus-associated lymphoid tissue in tolerant lung allograftsSatona Tanaka, Jason M Gauthier, Anja Fuchs, et al.Nature Aging|May 9, 2022
Profiling senescent cells in human brains reveals neurons with CDKN2D/p19 and tau neuropathologyShiva Kazempour Dehkordi, Jamie Walker, Eric Sah, et al.Proceedings of the National Academy of Sciences of the United States of America|November 1, 2012
Immunoglobulin-like transcript receptors on human dermal CD14+ dendritic cells act as a CD8-antagonist to control cytotoxic T cell primingJacques Banchereau, Sandra Zurawski, LuAnn Thompson-Snipes, et al.Pageof 50